Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction:...
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial
About this item
Full title
Author / Creator
on behalf of the Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group , Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group , Køber, Lars , Thomsen, Poul Erik Bloch , Møller, Mogens , Torp-Pedersen, Christian , Carlsen, Jan , Sandøe, Erik , Egstrup, Kenneth , Agner, Erik , Videbæk, Jørgen , Marchant, Bradley and Camm, A John
Publisher
London: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Arrhythmias cause much morbidity and mortality after myocardial infarction, but in previous trials, antiarrhythmic drug therapy has not been convincingly effective. Dofetilide, a new class III agent, was investigated for effects on all-cause mortality and morbidity in patients with left-ventricular dysfunction after myocardial infarction.
In 37...
Alternative Titles
Full title
Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial
Authors, Artists and Contributors
Author / Creator
Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group
Køber, Lars
Thomsen, Poul Erik Bloch
Møller, Mogens
Torp-Pedersen, Christian
Carlsen, Jan
Sandøe, Erik
Egstrup, Kenneth
Agner, Erik
Videbæk, Jørgen
Marchant, Bradley
Camm, A John
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_72511419
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_72511419
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(00)03402-4
